Prot #CPI-006-001: A Phase 1/1b Multicenter Study To Evaluate The Humanized Anti-CD73 Antibody, CPI-006, As A Single Agent or In Combination With Ciforadenant, with Pembrolizumab, And With Ciforadenant Plus Pembrolizumab In Adult Subjects With Advanced Ca

  • Sosman, Jeffrey Alan (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date12/20/19 → 12/20/22

Funding

  • Corvus Pharmaceuticals, Inc. ((OE) Prot #CPI-006-001)